Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome

Navarese Eliano Pio; Schulze Volker; Andreotti Felicita; Kowalewski Mariusz; Kolodziejczak Michalina; Kandzari David E.; Rassaf Tienush; Gorny Bartosz; Brockmeyer Maximilian; Meyer Christian; Berti Sergio; Kubica Jacek; Kelm Malte; Valgimigli Marco

首页> 外文期刊>JACC. Cardiovascular interventions >Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome

【24h】

Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome

机译：比伐卢定与肝素联合或不联合常规糖蛋白IIb / IIIa抑制剂对急性冠脉综合征患者安全性和有效性的综合荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVES The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with those of heparin with or without routine administration of a glycoprotein IIb/IIIa inhibitor (GPI) in patients with acute coronary syndrome (ACS).

机译：目的这项荟萃分析的目的是比较在急性冠状动脉综合征（ACS）患者中比伐卢定与肝素联合常规或不常规应用糖蛋白IIb / IIIa抑制剂（GPI）的30天安全性和有效性。

著录项

来源
《JACC. Cardiovascular interventions》 |2015年第1期|共13页
作者
Navarese Eliano Pio; Schulze Volker; Andreotti Felicita; Kowalewski Mariusz; Kolodziejczak Michalina; Kandzari David E.; Rassaf Tienush; Gorny Bartosz; Brockmeyer Maximilian; Meyer Christian; Berti Sergio; Kubica Jacek; Kelm Malte; Valgimigli Marco;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词
acute coronary syndrome; bivalirudin; GP IIb/IIIa inhibitor; heparin; meta-analysis;

机译：急性冠脉综合征;比伐卢定;GP IIb / IIIa抑制剂;肝素;meta分析;

相似文献

外文文献
中文文献
专利

1. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome [J] . Navarese Eliano Pio, Schulze Volker, Andreotti Felicita, JACC. Cardiovascular interventions . 2015,第1期

机译：比伐卢定与肝素联合或不联合常规糖蛋白IIb / IIIa抑制剂对急性冠脉综合征患者安全性和有效性的综合荟萃分析
2. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome [J] . JACC. Cardiovascular interventions . 2015,第1aPta2期

机译：在急性冠状动脉综合征患者中具有或不含常规糖蛋白IIB / IIIA抑制剂的综合性荟萃分析Bivalirudin与肝素的疗效和肝素
3. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome [J] . Navarese Eliano Pio, Schulze Volker, Andreotti Felicita, JACC. Cardiovascular interventions . 2015,第1aPta1期

机译：在急性冠状动脉综合征患者中具有或不含常规糖蛋白IIB / IIIA抑制剂的综合性荟萃分析Bivalirudin与肝素的疗效和肝素
4. The Long-Term Clinical Outcomes of Platelet Glycoprotein Ilb/IIIa Inhibitor Combined with Low Molecular Weight Heparin in Patients with Acute Coronary Syndrome [C] . J.H. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：血小板糖蛋白ILB / IIIa抑制剂的长期临床结果与急性冠状动脉综合征患者低分子量肝素联合
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [O] . Haiyan Xu, Bingjian Wang, Jing Yang, -1

机译：比伐卢定vs肝素加糖蛋白IIb / IIIa抑制剂在接受经皮冠状动脉介入治疗的妇女中：一项荟萃分析的随机对照试验。
7. Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome [O] . Navarese, E.P. (Eliano Pio), Schulze, V. (Volker), Andreotti, F. (Felicita), 2015

机译：比伐卢定与肝素联合或不联合常规糖蛋白IIb / IIIa抑制剂治疗急性冠脉综合征的安全性和有效性的综合荟萃分析

Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome

摘要

著录项

相似文献

相关主题

期刊订阅